14 | $AOLS a double rec | PoemStone | 05/02/2015 6:49:48 PM |
13 | $AOLS breakout candle. Pr. | PoemStone | 03/17/2015 7:55:15 PM |
12 | $AOLS cli | PoemStone | 08/15/2014 7:44:55 AM |
11 | $AOLS cli | PoemStone | 08/12/2014 8:18:03 PM |
10 | $AOLS bre | PoemStone | 08/08/2014 7:48:59 AM |
9 | AOLS Financials 07/15/2014 20:50:20 Aeolus | Emylers | 07/15/2014 9:50:18 PM |
8 | Latest Aeolus Pharmaceuticl (AOLS) Headlines | Stock_Tracker | 03/08/2014 8:29:28 PM |
7 | AOLS 0.2602 Stock Charts $AOLS 1 Month Chart | chartguy89 | 03/05/2014 10:11:28 PM |
6 | AOLS Recent News Aeolus Announces First Quarter | Stock_Tracker | 03/02/2014 4:16:59 PM |
5 | AOLS Recent News Aeolus Announces First Quarter | Stock_Tracker | 03/02/2014 1:58:19 PM |
4 | AOLS Stock Charts Saturday, February 22, 2014 at | chartguy89 | 02/22/2014 9:01:48 PM |
3 | AOLS Stock Chart 0.29 Monday, February 10, 2014 | chartguy89 | 02/10/2014 9:38:45 AM |
2 | AOLS $0.29 channel at resistance Shares | PoemStone | 11/02/2013 12:13:51 PM |
1 | AOLS Chart $0.275 PR off the bottom | PoemStone | 09/21/2013 9:11:21 PM |
Recent Articles
- Forvia Unveils Half-Year Financial Report for Public Review
- Avalanche Radar Market Growth to Exceed $75 Billion by 2032
- Ceres Power and Doosan Fuel Cell Launch Mass Production Initiative
- Elis Share Buybacks: Insights on Recent Trading Operations
- Kenmare Resources Welcomes New Dredges to Moma Mine
- Foresight Group Takes Action with Share Buyback Program
- Diversified Energy to Announce Q2 Financial Results Soon
- Bavarian Nordic Attracts Strong Acquisition Interest from Offeror
- Forvia Announces Financial Report Accessibility for H1 2025
- VAALCO Energy to Announce Earnings and Investors Call Soon
- Elis Reports Share Buyback Activity for Late July 2025
- Exploring Diversified Energy's Upcoming Financial Results Release
- OMS Energy Technologies Posts Impressive Fiscal Year 2025 Results
- Alteogen Advances with EYLUXVI® Approval for Eye Treatments
- Mill City Ventures III Ltd Shows Remarkable Stock Surge
- Ambassador Linda Thomas-Greenfield Joins Rendeavour Board
- Lleida.net Reports Significant EBITDA Growth of 33% in 2025
- BW Energy Enters New Chapter with Deepsea Mira Drilling Contract
- Howard Lutnick Discusses Upcoming Chip Import Probe Results
- Lleida.net Achieves Remarkable 33% Growth in Q2 2025 EBITDA
- RESVION Expands Its Portfolio with Tremonia Mobility Acquisition
- SCO Summit in China: Cultivating Unity and Collaboration
- FORVIA H1 2025: Insights on Growth and Strategic Changes
- Roche Advances Alzheimer’s Innovations with Groundbreaking Data
- Innovative Collaboration Between EnduroSat and WISeSat.Space
- Heineken N.V. Achieves Strong Growth in Half-Year Results
- Heineken Holding N.V. Shows Robust Growth in Half-Year Results
- BW Energy Expands Operations with Deepsea Mira Contract
- Bitcoin's Astounding Growth: Chamath's 2013 Call Wins Big
- Heineken N.V. Achieves Strong Half-Year Results for 2025
- FORVIA Reports Strong Half-Year Results and Confirms Guidance
- Heineken Holding N.V. Shows Commitment with Strong Half-Year Performance
- Ambassador Linda Thomas-Greenfield Joins Rendeavour's Vision
- Kalaam Telecom and SecurityHQ Join Forces for Cybersecurity Growth
- Steve Eisman's Take on Opendoor's Soaring Stock Price
- Akeso's Ivonescimab Receives NMPA Approval for Lung Cancer Treatment
- Revolutionizing Pet Eye Care: Dômes Pharma and Fear Free Unite
- Samsung's Bold $16.5 Billion Chip Deal to Compete in Tech Sector
- Exploring the Success of CBD Fair Guangzhou's 2025 Edition
- Economic Impact of Trump's Trade Deal: What Comes Next?
- Antengene Prepares for Major Presentation on ATG-022 at ESMO
- How Japan's $550 Billion Deal Can Boost TSMC's Growth in the US
- Hengrui Pharma and GSK Forge Agreement for Advanced Drug Development
- Time Is Running Out for Solar Tax Credit Savings with All Energy Solar
- US and China Seek Trade Solutions Amid Tariff Tensions
- Introducing Automate's Push PRO: Revolutionary Shade Control
- Exciting Esports World Cup Promotion from JBO Thailand
- Harbour BioMed Unveils Strong Profit Predictions for Future Growth
- Ascletis Begins Significant Obesity Study with ASC30 Drug
- Elpis Biopharmaceuticals Partners with NCCS for Groundbreaking Research